Your browser doesn't support javascript.
loading
Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial.
Garrison, Scott R; Kolber, Michael R; Allan, G Michael; Bakal, Jeffrey; Green, Lee; Singer, Alexander; Trueman, Darryl R; McAlister, Finlay A; Padwal, Raj S; Hill, Michael D; Manns, Braden; McGrail, Kimberlyn; O'Neill, Braden; Greiver, Michelle; Froentjes, Liesbeth S; Manca, Donna P; Mangin, Dee; Wong, Sabrina T; MacLean, Cathy; Kirkwood, Jessica Em; McCracken, Rita; McCormack, James P; Norris, Colleen; Korownyk, Tina.
Afiliação
  • Garrison SR; Family Medicine, University of Alberta, Edmonton, Alberta, Canada scott.garrison@ualberta.ca.
  • Kolber MR; Family Medicine, University of Alberta, Edmonton, Alberta, Canada.
  • Allan GM; Family Medicine, University of Alberta, Edmonton, Alberta, Canada.
  • Bakal J; Provincial Research Data Services, Alberta Health Services, Edmonton, Alberta, Canada.
  • Green L; Family Medicine, University of Alberta, Edmonton, Alberta, Canada.
  • Singer A; Family Medicine, University of Manitoba College of Medicine, Winnipeg, Manitoba, Canada.
  • Trueman DR; BedMed Patient Working Group, Edmonton, Alberta, Canada.
  • McAlister FA; Medicine, University of Alberta, Edmonton, Alberta, Canada.
  • Padwal RS; Medicine, University of Alberta, Edmonton, Alberta, Canada.
  • Hill MD; Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
  • Manns B; Nephrology, University of Calgary, Calgary, Alberta, Canada.
  • McGrail K; Centre for Health Services and Policy Research, University of British Columbia, Vancouver, British Columbia, Canada.
  • O'Neill B; Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Greiver M; Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Froentjes LS; Family Medicine, University of Alberta, Edmonton, Alberta, Canada.
  • Manca DP; Family Medicine, University of Alberta, Edmonton, Alberta, Canada.
  • Mangin D; Family Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Wong ST; Centre for Health Services and Policy Research, University of British Columbia, Vancouver, British Columbia, Canada.
  • MacLean C; Academic Family Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Kirkwood JE; Family Medicine, University of Alberta, Edmonton, Alberta, Canada.
  • McCracken R; Family Medicine, Providence Health Care, Vancouver, British Columbia, Canada.
  • McCormack JP; Family Practice, University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada.
  • Norris C; Faculty of Pharmaceutical Science, University of British Columbia, Vancouver, British Columbia, Canada.
  • Korownyk T; Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada.
BMJ Open ; 12(2): e059711, 2022 Feb 24.
Article em En | MEDLINE | ID: mdl-35210352

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Glaucoma Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Glaucoma Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article